Share Name Share Symbol Market Type Share ISIN Share Description
Realm Thera. LSE:RLM London Ordinary Share GB00B3XBCR18 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -1.33% 37.00p 36.00p 38.00p 37.50p 37.00p 37.50p 4,063 08:41:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -5.9 -0.8 - 50.95

Realm Thera. Share Discussion Threads

Showing 26 to 50 of 50 messages
Chat Pages: 2  1
DateSubjectAuthorDiscuss
16/11/2017
22:40
The price fall of the last few days has come with little volume: Volume for the first three days of this week were 45k, 85k and 5k.
cerrito
22/10/2017
18:02
Thanks smraynot for setting up this new thread. Noted it made yesterdays's FT Small Cap Focus...which was inaccurate referring to a £16m marcap rather than a £50m one.
cerrito
19/10/2017
16:49
Wonderful webcast yesterday. With quality management and positive phase 11 trials this share could absolutely rocket. My short term target in excess of £5.
smraynot
18/10/2017
13:21
very surprised and very pleasantly so by the share price increase today
cerrito
16/10/2017
14:52
The costs for this last fund raising seem very high but they did get 4 new investors to take 55m of the 66m new shares. PS are there holders who can set up a new thread?
cerrito
15/10/2017
22:02
Just seen that this last equity raise seems very expensive ie expenses of £1.6m for a raise with a gross value of £19.3m. Would total expenses have been so high in NYC?Reinforces the question as to why they are not in NYC given their 100% US and $ focus.
cerrito
23/9/2017
16:23
Nothing to surprise me in the interims and there does not appear to be any time slippages:I was however surprised by the equity raise. Given their current cash burn they have enough to continue to middle of next year when they are due to announce their top line data readout for both programmes and on the basis that al least one-preferably PR022- is positive then the share price should be much higher. Not sure if I will be able to make the conference call
cerrito
11/9/2017
06:56
Good news today on PR013 and that they seem to be on schedule outlined in November last year to commence clinical trials this year.
cerrito
02/8/2017
18:21
Good that they meet their target to submit IND approval in Q3 for PR013; also good that still expecting to start PR022 Phase II this year. See that today’s news moved the share price up abit-only 15K-ie £5k- of shares traded which actually is equal to the total trades of the last 16 days-so illiquid are the shares. Of course FX rate a big factor in setting the share price and current weakness reflects $ weakness against the £. Also makes one wonder why this US company has a quote on AIM;I bought this up at the AGM and got reasonable reassurance on this. Happy with what I have and no current plans to buy or sell
cerrito
24/3/2017
20:46
I see the price has dropped following the full year figures and AR, though I cannot think why as nothing new..perhaps it was the results call...anyone hear it??
cerrito
13/3/2017
21:03
FT has two articles on fact that FDA about to approve Sanofi/Regeneuron's dupilumab-as has been anticipated by RLM. Remember PR022 is for the mild to moderate market and dupilimab for the moderate/severe. https://www.ft.com/content/ac4f2990-05cf-11e7-ace0-1ce02ef0def9 is interesting on pricing aspects
cerrito
28/2/2017
19:31
Market rather yawned at Realm's news this morning; I know that for operational reasons they were very keen to get this permission quickly which they have done.
cerrito
30/1/2017
13:32
If you would like to listen to the presentation given by CEO Alex Martin at our previous investor forum the recording is now available at: hxxps://www.equitydevelopment.co.uk/webinars/?d=%3D%3DQO1IjM Kind regards, The Equity Development team
hannahh
26/1/2017
13:19
Yes be good if anyone who follws RLM and who has the ability to set up a new board can do so. I will try and write up meeting last night and Equity Development have produced a (to me) V informative note.
cerrito
26/1/2017
00:53
Is this BB going to morph into a Realm Therapeutics BB?
gnnmartin
17/1/2017
14:12
If you would like to hear Alex Martin, Chief Executive Officer, present on behalf of Realm Therapeutics he will be appearing at our next investor forum on the evening of Wednesday 25th of January. Also appearing will be the management of Ergomed and Kromek. To learn more about the forum and to register for free please follow this link: hxxps://www.eventbrite.co.uk/e/equity-development-investor-forum-january-2017-tickets-30349576400 Thanks, The Equity Development team
hannahh
15/9/2011
19:40
SLE mid price 22.125p = C$1.16 per RLM share.
buffin
06/9/2011
13:37
SLE mid price 20.5p = C$1.08 per RLM share.
buffin
01/9/2011
20:41
Trading at the equivalent of 17.8p per SLE share.
buffin
26/8/2011
15:52
http://tmx.quotemedia.com/article.php?newsid=44135636&qm_symbol=RLM:CA $1.30 per share
dicko80
26/8/2011
15:45
Takeover offer from San Leon Energy today see SLE thread
parvo
13/8/2011
15:29
Realm's AGM presentation confirms (p20 on Acrobat, slide numbered 19) that they plan to start the permitting process for the first well in the Wegrow concession in Q4. http://www.realmenergy.ca/assets/pdf/REALM-Presentation_072111.pdf The market cap @ 95c is C$103m, less cash and near cash C$26m = enterprise value of C$77m. Their net Polish Baltic acreage is 374k, so a mere C$206 an acre. Their total net Polish acreage is 465k, so an even more mere C$166 an acre. That allows nothing for Germany or France, which may turn out to be realistic.
buffin
22/7/2011
14:24
The past few weeks have seen some big M+A plays developing in shale in the US, writes Nick Grealy. http://www.nohotair.co.uk/2011/63-shale-gas/2073-is-shale-de-risking.html and he concludes I think that there are any number of European shale players who have for various reasons languished the last few years. Many of them are no riskier than tens of US or Canadian counterparts and the market should, and will, realise the value of them. I'm not in the stock picking business, but anyone anywhere in Europe deserves to be looked at as providing good value: European gas prices are high, taxes are low and the overall regulatory environment and regulatory risk has been overstated. Fortune favours the brave, or simply unconventional wisdom.
buffin
21/7/2011
13:58
Shares of unconventional gas explorer Realm Energy International have moved significantly, driven by market speculation of an impending deal. Realm shares changed hands as high as CDN $1.14 today, moving smartly from their closing price of $0.66 on May 27th, when the company announced that it has retained GMP Securities as part of initiating a process to "identify, examine and consider a range of strategic alternatives available in connection with its interests in Poland." The share activity has been driven in part by the recent regulatory filings of two significant Realm shareholders. Soros Fund Management LLC and Enso Capital Management LLC, both reported that they had entered into a voting and tender agreement with an unidentified third party, who was "proposing to acquire all of the issued and outstanding shares" of Realm. As of June 30th, the Soros managed Quantum investment fund held 16.15 % of Realm's shares and additional share purchase warrants that, if exercised, would increase its ownership position to 21.01%. As of the same date, Enso Capital said that it exercised control or direction of over 15.58% of Realm's shares, assuming the exercise of its share purchase warrants. Last week Realm announced that it had entered into a farm-out agreement with ConocoPhillips to conduct joint exploration on licences that may be awarded as a result of these applications made by Realm in France's prospective Paris Basin. Realm has made applications for exploration licences for 1.65 million acres in the Paris basin. Officials at Realm would not comment on market activity or on the status of the on-going strategic review. http://naturalgasforeurope.com/realm-energy-bid-speculation.htm
buffin
15/7/2011
12:16
REALM ENERGY ANNOUNCES JOINT PARTICIPATION WITH CONOCOPHILLIPS IN PARIS BASIN Realm Energy International Corp. has entered into a farm-out agreement with ConocoPhillips to conduct joint exploration activities in the Paris basin in France. Realm Energy has made applications for exploration licences for 1.65 million acres in the Paris basin. The applications comprise nine separate exploration permits and include all rights to explore for oil and gas in all formations underlying the lands. The time frame for making applications for the licences has ended. Realm Energy has entered into a farm-out agreement with ConocoPhillips for the purpose of conducting joint exploration activities on selected exploration licences that may be awarded as a result of these applications. The farm-out agreement provides Realm Energy with a limited carry on exploration expenditures and financial incentives conditional on acreage acquired and activity levels permitted by the government. Realm Energy will be the designated operator for the initial exploration phase, and ConocoPhillips has the option to operate thereafter. The farm-out agreement is conditional on the final award to Realm Energy of permits for a portion of the lands in the Paris basin, and government approval of the joint participation of Realm Energy and ConocoPhillips. Craig Steinke, chief executive officer of Realm Energy, stated: "ConocoPhillips brings a wealth of experience in oil and gas operations as well as a high level of health, safety and environmental standards. Realm Energy is looking forward to working with ConocoPhillips on joint operations in France and having a long and successful partnership." Exploration activities in the Paris basin are currently restricted by the government of France so as to prohibit hydraulic fracturing as part of the petroleum exploration and development process. In connection with their joint exploration activities, Realm Energy and ConocoPhillips will comply fully with all relevant legislation governing petroleum operations in France. http://www.stockwatch.com/News/Item.aspx?bid=Z-C:RLM-1861885&symbol=RLM&news_region=C Nick Grealy points out COP have also done a deal with 3Legs. They've also entered into heads of agreement with Australia's New Standard Energy. http://www.abc.net.au/rural/news/content/201107/s3269312.htm
buffin
Chat Pages: 2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171215 16:02:29